Ventyx Biosciences, Inc. (VTYX) Misses Q2 EPS by 21c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance